血管 (JP Patent Analysis Report)
The Technical Field "血管" had 150 patent application filings in the most recent period (2023-01-01 to 2023-04-30). This is a significantly decreased of -458 filings (-75.3%) over 608 they had in the same period of the previous year (2022-01-01 to 2022-04-30).
The highest number of filings in 2016 with 2,918 cases, and their lowest number in 2023 with 239 cases.
The mean of the number of filings over the last 5 years (2019 to 2024, 9,071 cases in total) is 1,512, and the median is 1,924. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 1,512 patents |
| Std Dev | 1,018 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 239 cases | -86.4 % |
| 2022 year | 1,757 cases | -15.97 % |
| 2021 year | 2,091 cases | -5.56 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 血管 for the period of the last 10 years (2015-01-01 to 2024-12-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 血管, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
血管, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 血管 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 20,233 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
血管
Related Patent Analysis Report
A patent aanlysis report on the following synonyms was found in the technical term "血管".
- 血管 (Main page / Including the following synonyms)
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 血管 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, テルモ株式会社 has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 24 cases, followed by キヤノンメディカルシステムズ株式会社 with 22 cases.
| Name | Cases |
|---|---|
| テルモ株式会社 | 24 cases |
| キヤノンメディカルシステムズ株式会社 | 22 cases |
| キヤノン株式会社 | 3 cases |
| ジェネンテックインコーポレイテッド | 2 cases |
| 富士フイルム株式会社 | 1 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Comparing the number of applications of each company, コーニンクレッカフィリップスエヌヴェ has the highest number of joint applications in the last for the target period (2015 to 2025) with 374 cases, followed by テルモ株式会社 with 366 cases.
| Name | Cases |
|---|---|
| コーニンクレッカフィリップスエヌヴェ | 374 cases |
| テルモ株式会社 | 366 cases |
| キヤノンメディカルシステムズ株式会社 | 244 cases |
| 富士フイルム株式会社 | 210 cases |
| ノバルティスアーゲー | 165 cases |
| ジェネンテックインコーポレイテッド | 162 cases |
| キヤノン株式会社 | 161 cases |
| エフホフマン-ラロシュアーゲー | 96 cases |
| メルクパテントゲゼルシャフトミットベシュレンクテルハフツング | 49 cases |
| ボストンサイエンティフィックリミテッド | 6 cases |
| 株式会社東芝 | 4 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 血管 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Among the top coapplicants, テルモ株式会社 has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 24 cases, followed by キヤノンメディカルシステムズ株式会社 with 22 cases.
| Name | Cases |
|---|---|
| テルモ株式会社 | 24 cases |
| キヤノンメディカルシステムズ株式会社 | 22 cases |
| ジェネンテックインコーポレイテッド | 2 cases |
| 富士フイルム株式会社 | 1 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Among the top coapplicants, コーニンクレッカフィリップスエヌヴェ has the highest number of joint applications in the last for the target period (2015 to 2025) with 374 cases, followed by テルモ株式会社 with 366 cases.
| Name | Cases |
|---|---|
| コーニンクレッカフィリップスエヌヴェ | 374 cases |
| テルモ株式会社 | 366 cases |
| キヤノンメディカルシステムズ株式会社 | 244 cases |
| 富士フイルム株式会社 | 210 cases |
| ノバルティスアーゲー | 165 cases |
| ジェネンテックインコーポレイテッド | 162 cases |
| 株式会社東芝 | 4 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by 血管’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 血管’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with テルモ株式会社
血管 filed 366 joint applications with テルモ株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 183 cases in total) is 30.5, and the median is 29.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2017 with 54 cases, and their lowest number in 2023 with 24 cases.
| Index | Value |
|---|---|
| Average | 30.5 patents |
| Std Dev | 17.3 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 24 cases | -52.9 % |
| 2022 year | 51 cases | +2.00 % |
| 2021 year | 50 cases | +92.3 % |
Trends in filing of joint patent applications with コーニンクレッカフィリップスエヌヴェ
血管 filed 374 joint applications with コーニンクレッカフィリップスエヌヴェ for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 144 cases in total) is 24.0, and the median is 24.0. The coefficient of variation (standard deviation/mean) is 0.9, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2015 with 72 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 24.0 patents |
| Std Dev | 22.2 |
| COV | 0.9 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 22 cases | -26.67 % |
| 2021 year | 30 cases | +15.38 % |
| 2020 year | 26 cases | -60.6 % |
Trends in filing of joint patent applications with キヤノンメディカルシステムズ株式会社
血管 filed 244 joint applications with キヤノンメディカルシステムズ株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 118 cases in total) is 19.7, and the median is 23.0. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
The highest number of filings in 2017 with 41 cases, and their lowest number in 2023 with 17 cases.
| Index | Value |
|---|---|
| Average | 19.7 patents |
| Std Dev | 7.2 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 17 cases | -19.05 % |
| 2022 year | 21 cases | -16.00 % |
| 2021 year | 25 cases | 0 |
Trends in filing of joint patent applications with ノバルティスアーゲー
血管 filed 165 joint applications with ノバルティスアーゲー for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 52 cases in total) is 8.7, and the median is 11.5. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2016 with 38 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 8.7 patents |
| Std Dev | 6.3 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 12 cases | +9.09 % |
| 2021 year | 11 cases | -21.43 % |
| 2020 year | 14 cases | -6.67 % |
Trends in filing of joint patent applications with 富士フイルム株式会社
血管 filed 210 joint applications with 富士フイルム株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 84 cases in total) is 14.0, and the median is 16.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2015 with 36 cases, and their lowest number in 2023 with 1 cases.
| Index | Value |
|---|---|
| Average | 14.0 patents |
| Std Dev | 10.6 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 1 cases | -95.0 % |
| 2022 year | 20 cases | +66.7 % |
| 2021 year | 12 cases | -53.8 % |
Information on important patents (JP)
The following shows JP patents held by 血管 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 血管’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 血管 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 8 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.2 times. The most recently Invalidation Trial patent is 特許6995822 "ＤＰＰ ＩＶインヒビターの使用" (Invalidation Trial day 2024-06-25) , next is 特許7258832 "多発性硬化症を処置するためのＳ１Ｐ受容体モジュレーター" (Invalidation Trial day 2024-05-08) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許6995822 | ＤＰＰ ＩＶインヒビターの使用 | 2024-06-25 |
| 2 | 特許7258832 | 多発性硬化症を処置するためのＳ１Ｐ受容体モジュレーター | 2024-05-08 |
| 3 | 特許6556767 | ＤＰＰ−４阻害剤（リナグリプチン）を任意で他の抗糖尿病薬と組み合わせて含む抗糖尿病薬 | 2024-03-19 |
| 4 | 特許6189374 | 糖尿病療法 | 2024-01-31 |
| 5 | 特許5734564 | ＤＰＰ ＩＶインヒビターの使用 | 2023-07-10 |
| 6 | 特許6931019 | 多発性硬化症を処置するためのＳ１Ｐ受容体モジュレーター | 2023-06-30 |
| 7 | 特許5813293 | ＤＰＰ ＩＶインヒビターの使用 | 2023-03-07 |
| 8 | 特許4874482 | アスピリンを含有する医薬組成物 | 2022-02-22 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 5 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許6466538 "治療薬のＣＮＳ送達" (1 times) , and the next most invalidation trial patent is 特許6522072 "イズロン酸−２−スルファターゼのＣＮＳ送達のための方法および組成物" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6466538 | 治療薬のＣＮＳ送達 | 1 times |
| 2 | 特許6522072 | イズロン酸−２−スルファターゼのＣＮＳ送達のための方法および組成物 | 1 times |
| 3 | 特許6189374 | 糖尿病療法 | 1 times |
| 4 | 特許6293103 | 自己緩衝タンパク質製剤 | 1 times |
| 5 | 特許6556767 | ＤＰＰ−４阻害剤（リナグリプチン）を任意で他の抗糖尿病薬と組み合わせて含む抗糖尿病薬 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 18 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7492459 "加齢に関連する状態の診断及び治療のための組成物及び方法" (Opposition day 2024-11-27) , next is 特許7446003 "マカ抽出物及びその用途" (Opposition day 2024-09-04) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7492459 | 加齢に関連する状態の診断及び治療のための組成物及び方法 | 2024-11-27 |
| 2 | 特許7446003 | マカ抽出物及びその用途 | 2024-09-04 |
| 3 | 特許7471069 | 移植片の活性を高める方法 | 2024-08-15 |
| 4 | 特許7391562 | 電気生理学的マッピングカテーテル用の単極基準電極 | 2024-05-15 |
| 5 | 特許7362753 | ガイド延長カテーテル | 2024-04-10 |
| 6 | 特許7344565 | 未分化細胞検出法 | 2024-03-13 |
| 7 | 特許7298844 | 細胞培養物の製造方法 | 2023-12-26 |
| 8 | 特許7289655 | ＰＡＭＰＳ及びＤＡＭＰＳの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2023-12-12 |
| 9 | 特許7210036 | アルツハイマー病および他の神経変性障害のためのバイオマーカーおよび診断方法 | 2023-07-20 |
| 10 | 特許7208971 | 延長チューブポートプローブへのアクセスが改善された統合型末梢静脈内カテーテル | 2023-07-18 |
Protested cases
List of latest Protested patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 30 patents Protest from third parties. The average number of Protest is 1.5 times. The most recently Protest patent is 特開2022-011494 "エラスチン産生促進剤及びその製造方法" (Protest day 2024-12-10) , next is 特開2024-080709 "移植片の活性を高める方法" (Protest day 2024-11-28) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2022-011494 | エラスチン産生促進剤及びその製造方法 | 2024-12-10 |
| 2 | 特開2024-080709 | 移植片の活性を高める方法 | 2024-11-28 |
| 3 | 特表2024-504870 | 含窒素架橋複素環化合物、その調製方法及びその医薬的応用 | 2024-09-02 |
| 4 | 特表2022-502482 | 骨損傷を治療するための組成物及び方法 | 2024-07-19 |
| 5 | 特開2023-168547 | 眼科組成物 | 2024-06-26 |
| 6 | 特開2022-185763 | 模擬血管 | 2024-05-14 |
| 7 | 特表2023-531169 | 熱希釈作用および身体閉塞破壊作用の両方を有するカテーテル・システム、ならびに血流量を判定し、身体閉塞破壊を実行するための方法 | 2024-02-20 |
| 8 | 特許7446003 | マカ抽出物及びその用途 | 2024-02-16 |
| 9 | 特開2023-052609 | 細胞培養物の製造方法 | 2024-01-23 |
| 10 | 特開2023-055917 | ＰＡＭＰＳ及びＤＡＭＰＳの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2024-01-17 |
| 11 | 特開2020-186205 | 血管拡張剤 | 2023-12-21 |
| 12 | 特許7553496 | 眼科用製剤 | 2023-11-15 |
| 13 | 特許7524072 | 敗血症および敗血症性ショックの治療 | 2023-11-06 |
| 14 | 特開2020-114266 | ＩｇＧ Ｆｃドメインを有する融合タンパク質の生産方法 | 2023-10-30 |
| 15 | 特許7435442 | 血管内皮機能改善用又は末梢血管の血流改善用組成物 | 2023-08-30 |
| 16 | 特開2023-098949 | 多発性硬化症を処置するためのＳ１Ｐ受容体モジュレーター | 2023-08-28 |
| 17 | 特許7471069 | 移植片の活性を高める方法 | 2023-08-09 |
| 18 | 特開2023-036582 | がんのための治療方法及び診断方法 | 2023-06-26 |
| 19 | 特表2021-530463 | ｍＴＯＲ阻害剤の無水組成物および使用方法 | 2023-01-19 |
| 20 | 特開2022-172083 | 癌のための治療方法及び診断方法 | 2023-01-17 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 81 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.5. The most protest patent is 特許7320919 "小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療" (10 times) , and the next most protest patent is 特開2017-061467 "血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用" (5 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7320919 | 小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療 | 10 times |
| 2 | 特開2017-061467 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 5 times |
| 3 | 特表2019-528113 | 機械学習モデルを使用した眼底画像の処理 | 5 times |
| 4 | 特開2019-167366 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 4 times |
| 5 | 特開2020-114266 | ＩｇＧ Ｆｃドメインを有する融合タンパク質の生産方法 | 4 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 334 patents Inspection from third parties. The average number of Inspection is 1.3 times. The most recently Inspection patent is 特表2022-550734 "ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数（ＭＰＩ）を改善する方法" (Inspection day 2024-12-27) , next is 特表2024-502698 "生理学的センサを有する心房間シャント" (Inspection day 2024-12-24) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2022-550734 | ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数（ＭＰＩ）を改善する方法 | 2024-12-27 |
| 2 | 特表2024-502698 | 生理学的センサを有する心房間シャント | 2024-12-24 |
| 3 | 特表2023-524732 | 生体内で縮小および増大させられることができる寸法を伴うデバイス | 2024-12-24 |
| 4 | 特開2023-033400 | 長期循環物質のないポロクサマー組成物、その産生方法およびその使用 | 2024-12-17 |
| 5 | 特表2023-509263 | アフリベルセプトをコードするＡＡＶ２バリアントを使用する眼内血管新生疾患を処置する方法 | 2024-12-10 |
| 6 | 特表2022-532564 | 先駆制御性細胞栄養芽細胞およびその使用 | 2024-12-10 |
| 7 | 特表2024-529629 | 血管内心房細動治療システムおよび方法 | 2024-12-09 |
| 8 | 特開2024-080709 | 移植片の活性を高める方法 | 2024-12-05 |
| 9 | 特開2023-169426 | ガスシールパッド | 2024-11-26 |
| 10 | 特表2022-526416 | ユニット型の血管採取装置及びその使用方法 | 2024-11-25 |
| 11 | 特表2021-525595 | 薄型多剤注入システムおよび方法 | 2024-11-22 |
| 12 | 特表2022-531272 | 切断要素の配向を識別するために視覚的な手がかりを備える単一の内視鏡血管採取装置 | 2024-11-22 |
| 13 | 特表2022-517456 | 臓器健康および疾患をモニタリングするための方法およびシステム | 2024-11-21 |
| 14 | 特開2024-119945 | 経頸動脈神経血管カテーテル | 2024-11-08 |
| 15 | 特表2024-532430 | 血管の経皮的閉鎖の検出および圧力除去 | 2024-11-08 |
| 16 | 特表2023-537955 | 経頸動脈処置用バルーンカテーテル | 2024-11-08 |
| 17 | 特表2024-545417 | 複数のブリッジ長さパターンを備えたステント | 2024-11-08 |
| 18 | 特開2024-150567 | 頚動脈血流の逆流を確立する方法およびシステム | 2024-11-08 |
| 19 | 特表2022-554273 | 経カテーテル大動脈弁治療のためのシステム及び方法 | 2024-11-08 |
| 20 | 特表2022-554318 | 神経血管インターベンションシステム及び方法 | 2024-11-08 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 612 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.3. The most inspection patent is 特開2017-149726 "Ｂ細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療" (46 times) , and the next most inspection patent is 特許7320919 "小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療" (20 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2017-149726 | Ｂ細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療 | 46 times |
| 2 | 特許7320919 | 小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療 | 20 times |
| 3 | 特開2019-167366 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 10 times |
| 4 | 特開2018-131469 | 磁気双極子安定化溶液の使用を含む疾患を処置または改善する方法および行動を向上させる方法 | 9 times |
| 5 | 特開2017-061467 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 8 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 3,646 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.6. The most cited patent is 特許6285383 "画像処理装置、内視鏡システム、画像処理装置の作動方法、及び内視鏡システムの作動方法" (95 times) , and the next most cited patent is 特許6683367 "生体情報計測装置、生体情報計測方法及び生体情報計測プログラム" (45 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6285383 | 画像処理装置、内視鏡システム、画像処理装置の作動方法、及び内視鏡システムの作動方法 | 95 times |
| 2 | 特許6683367 | 生体情報計測装置、生体情報計測方法及び生体情報計測プログラム | 45 times |
| 3 | 特開2016-193222 | 画像を分析するための方法および装置 | 45 times |
| 4 | 特許7046924 | 血管から閉塞性血塊を除去するための血塊回収装置 | 38 times |
| 5 | 特許6528608 | 診断装置、及び診断装置における学習処理方法、並びにプログラム | 37 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.